MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing workplace safety with a novel AI-powered system that identifies drug and alcohol impairment through voice analysis. The technology, first of its kind globally, is initially targeting the South American mining sector, where remote operations and heavy machinery make safety monitoring critical.
According to a recent article discussing the innovation, MindBio has spent several years researching intoxication detection. The company developed a voice-based AI system that analyzes acoustic patterns in speech to estimate intoxication levels within seconds. This approach moves beyond traditional biological testing methods such as breathalyzers or laboratory samples. The platform is being developed for enterprise use, with the company currently preparing a hardware kiosk system that can screen workers as they enter industrial facilities. The full article is available at https://ibn.fm/ZPBcc.
MindBio’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, relying solely on the human voice. The company is building an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detection of drug and alcohol intoxication. These kiosks are designed for a range of enterprise environments, including mining, aviation, construction, and law enforcement.
The implications of this announcement are significant for workplace safety. Traditional impairment testing methods can be intrusive, time-consuming, and require sample collection. MindBio’s voice-based system offers a non-invasive, quick, and scalable alternative. In industries like mining, where workers operate heavy machinery in remote locations, the ability to rapidly screen for impairment could reduce accidents and save lives. The technology also addresses the growing need for efficient safety protocols in high-risk environments.
MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company’s focus on the mining sector first suggests a strategic entry point into industries with stringent safety requirements. As the platform expands to aviation, construction, and law enforcement, it could set new standards for impairment testing.
For more information about MindBio Therapeutics, visit the company’s newsroom at https://ibn.fm/MBQIF.
